v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
Research and development $ 5,118 $ 1,442 $ 9,192 $ 2,426
General and administrative 4,132 1,466 7,929 2,241
Total operating expenses 9,250 2,908 17,121 4,667
Operating loss (9,250) (2,908) (17,121) (4,667)
Other (expense) income:        
Interest expense - royalty agreement (1,354) (942) (2,569) (1,747)
Interest expense - convertible notes payable 0 (29) 0 (29)
Fair value adjustments on derivative liabilities - royalty agreement (118) (271) (193) (329)
Interest income (expense), net 690 (86) 1,442 0
Other income, net 561 64 785 64
Loss before income taxes (9,471) (4,172) (17,656) (6,708)
Income tax benefit (expense) 0 0 0 0
Net loss (9,471) (4,172) (17,656) (6,708)
Less: Cumulative Series D preferred dividends 0 (194) 0 (388)
Loss attributable to common stockholders (9,471) (4,366) (17,656) (7,096)
Other comprehensive loss:        
Foreign currency translation loss (108) 0 (114) 0
Comprehensive loss $ (9,579) $ (4,366) $ (17,770) $ (7,096)
Net loss per share of common stock - basic (in dollars per share) $ (0.86) $ (2.47) $ (1.6) $ (4.01)
Net loss per share of common stock - diluted (in dollars per share) $ (0.86) $ (2.47) $ (1.6) $ (4.01)
Weighted-average shares used in computing net loss per share of common stock - basic (in shares) 11,052,741 1,770,167 11,033,327 1,770,167
Weighted-average shares used in computing net loss per share of common stock - diluted (in shares) 11,052,741 1,770,167 11,033,327 1,770,167